Company registration number SC621746 (Scotland)
MACDUFF MEDICAL LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
PAGES FOR FILING WITH REGISTRAR
MACDUFF MEDICAL LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
MACDUFF MEDICAL LTD
BALANCE SHEET
AS AT 28 FEBRUARY 2025
28 February 2025
- 1 -
28 February 2025
29 February 2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
633
1,766
Current assets
Debtors
5
7,952
10,036
Cash at bank and in hand
228,741
215,970
236,693
226,006
Creditors: amounts falling due within one year
6
(16,580)
(41,535)
Net current assets
220,113
184,471
Total assets less current liabilities
220,746
186,237
Provisions for liabilities
(158)
(414)
Net assets
220,588
185,823
Capital and reserves
Called up share capital
2
2
Profit and loss reserves
220,586
185,821
Total equity
220,588
185,823

For the financial year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 29 October 2025 and are signed on its behalf by:
Dr R MacDuff
Director
Company registration number SC621746 (Scotland)
MACDUFF MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
- 2 -
1
Accounting policies
Company information

MacDuff Medical Ltd is a private company limited by shares incorporated in Scotland. The registered office is 6th Floor, Gordon Chambers, 90 Mitchell Street, Glasgow, Scotland, G1 3NQ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% on a reducing balance basis
Computers
33% on a straight line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

MACDUFF MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
1
Accounting policies
(Continued)
- 3 -
1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.7
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
MACDUFF MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
- 4 -
4
Tangible fixed assets
Plant and equipment
Computers
Total
£
£
£
Cost
At 1 March 2024 and 28 February 2025
1,240
5,311
6,551
Depreciation and impairment
At 1 March 2024
543
4,242
4,785
Depreciation charged in the year
174
959
1,133
At 28 February 2025
717
5,201
5,918
Carrying amount
At 28 February 2025
523
110
633
At 29 February 2024
697
1,069
1,766
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
7,952
10,036
6
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
14,862
10,726
Other creditors
1,718
30,809
16,580
41,535
2025-02-28 2024-03-01 false false false CCH Software CCH Accounts Production 2025.200 No description of principal activity Dr R MacDuff Dr E M MacDuff SC621746 2024-03-01 2025-02-28 SC621746 2025-02-28 SC621746 2024-02-29 SC621746 core:PlantMachinery 2025-02-28 SC621746 core:ComputerEquipment 2025-02-28 SC621746 core:PlantMachinery 2024-02-29 SC621746 core:ComputerEquipment 2024-02-29 SC621746 core:ShareCapital 2025-02-28 SC621746 core:ShareCapital 2024-02-29 SC621746 core:RetainedEarningsAccumulatedLosses 2025-02-28 SC621746 core:RetainedEarningsAccumulatedLosses 2024-02-29 SC621746 bus:Director1 2024-03-01 2025-02-28 SC621746 core:PlantMachinery 2024-03-01 2025-02-28 SC621746 core:ComputerEquipment 2024-03-01 2025-02-28 SC621746 2023-03-01 2024-02-29 SC621746 core:PlantMachinery 2024-02-29 SC621746 core:ComputerEquipment 2024-02-29 SC621746 2024-02-29 SC621746 core:WithinOneYear 2025-02-28 SC621746 core:WithinOneYear 2024-02-29 SC621746 core:CurrentFinancialInstruments 2025-02-28 SC621746 core:CurrentFinancialInstruments 2024-02-29 SC621746 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 SC621746 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 SC621746 bus:FRS102 2024-03-01 2025-02-28 SC621746 bus:AuditExempt-NoAccountantsReport 2024-03-01 2025-02-28 SC621746 bus:Director2 2024-03-01 2025-02-28 SC621746 bus:FullAccounts 2024-03-01 2025-02-28 xbrli:pure xbrli:shares iso4217:GBP